Synthetic peptide (the amino acid sequence is considered to be commercially sensitive) (Human C terminal)
Our Abpromise guarantee covers the use of ab20204 in the following tested applications.
The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
|IHC-Fr||Use at an assay dependent dilution.|
|IHC-P||Use at an assay dependent dilution.|
|WB||Use at an assay dependent dilution. Predicted molecular weight: 60 kDa.|
ab20204 has not yet been referenced specifically in any publications.